DLHC
Get informed when a big investor buys or sells
+ FollowUndervalued by 181.5% based on the discounted cash flow analysis.
| Market cap | $76.23 Million |
|---|---|
| Enterprise Value | $221.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | 1.45 |
| Outstanding Shares | 14,388,000 |
| P/E Ratio | -16.65 |
|---|---|
| PEG | 4.28 |
| Price to Sales | 0.26 |
| Price to Book Ratio | 0.75 |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | 29.84 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 1.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 66.17%▼ 1.13% |
|---|---|
| Total Invested | $55.41M▲ 1.28% |
| Investors Holding | 43▼ 2.00% |
No data
DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's s...